Abstract:Background: The risk of cardiovascular disease in type 1 diabetes remains extremely high, despite marked advances in blood glucose control and even the widespread use of cholesterol synthesis inhibitors. Thus, a deeper understanding of insulin regulation of cholesterol metabolism, and its disruption in type 1 diabetes, could reveal better treatment strategies. Methods: To define the mechanisms by which insulin controls plasma cholesterol levels, we knocked down the insulin receptor, FoxO1, and the key bile acid synthesis enzyme, CYP8B1. We measured bile acid composition, cholesterol absorption, and plasma cholesterol. In parallel, we measured markers of cholesterol absorption and synthesis in humans with type 1 diabetes treated with ezetimibe and simvastatin in a double-blind crossover study. Results: Mice with hepatic deletion of the insulin receptor showed marked increases in 12α-hydroxylated bile acids, cholesterol absorption, and plasma cholesterol. This phenotype was entirely reversed by hepatic deletion of FoxO1. FoxO1 is inhibited by insulin and required for the production of 12α-hydroxylated bile acids, which promote intestinal cholesterol absorption and suppress hepatic cholesterol synthesis. Knockdown of Cyp8b1 normalized 12α-hydroxylated bile acid levels and completely prevented hypercholesterolemia in mice with hepatic deletion of the insulin receptor (n=5-30), as well as mouse models of type 1 diabetes (n=5-22). In parallel, the cholesterol absorption inhibitor, ezetimibe, normalized cholesterol absorption and low-density lipoprotein cholesterol in patients with type 1 diabetes as well as, or better than, the cholesterol synthesis inhibitor, simvastatin (n=20). Conclusions: Insulin, by inhibiting FoxO1 in the liver, reduces 12α-hydroxylated bile acids, cholesterol absorption, and plasma cholesterol levels. Thus, type 1 diabetes leads to a unique set of derangements in cholesterol metabolism, with increased absorption rather than synthesis. These derangements are reversed by ezetimibe, but not statins, which are currently the first line of lipid-lowering treatment in type 1 diabetes. Taken together, these data suggest that a personalized approach to lipid lowering in type 1 diabetes may be more effective and highlight the need for further studies specifically in this group of patients.

Impact of Perturbed Pancreatic β-Cell Cholesterol Homeostasis on Adipose Tissue and Skeletal Muscle Metabolism

Impact Of Perturbed Pancreatic Beta-Cell Cholesterol Homeostasis On Adipose Tissue And Skeletal Muscle Metabolism (Vol 65, Pg 3610, 2016)

Cholesterol metabolism, pancreatic β-cell function and diabetes

Persistent Inflammatory Lipotoxicity Impedes Pancreatic β-cell Function in Diet-Induced Obese Mice Despite Correction of Glucotoxicity

Insulin Prevents Hypercholesterolemia by Suppressing 12α-Hydroxylated Bile Acids

Abstract 523: Regulation of Pancreatic Β-Cell Gene Expression and Function by ABCA1 and ABCG1

Pancreatic adipocytes mediate hypersecretion of insulin in diabetes-susceptible mice

Osteocalcin protects islet identity in LDL receptor knockout mice on high fat diet

Intracellular lipid metabolism impairs β cell compensation during diet-induced obesity.

Insulin Rescued MCP-1-Suppressed Cholesterol Efflux to Large HDL2 Particles Via ABCA1, ABCG1, SR-BI and PI3K/Akt Activation in Adipocytes

Pancreatic PCSK9 controls the organization of the β-cell secretory pathway via LDLR-cholesterol axis

Skeletal Muscle Phospholipid Metabolism Regulates Insulin Sensitivity and Contractile Function

Effect of Hypertriglyceridemia on Beta Cell Mass and Function in ApoC3 Transgenic Mice*

Cholesterol Sulfate Exerts Protective Effect on Pancreatic β-Cells by Regulating β-Cell Mass and Insulin Secretion

Impaired Adiponectin Signaling Contributes to Disturbed Catabolism of Branched-Chain Amino Acids in Diabetic Mice

Pathway Attenuation of Fatty Acid Beta-Oxidation in the Skeletal Muscle of a Type 2 Diabetic Mouse Model

Pathological Roles of Bone Marrow Adipocyte-Derived Monocyte Chemotactic Protein-1 in Type 2 Diabetic Mice

Mechanisms of Impaired Pancreatic Β‑cell Function in High‑fat Diet‑induced Obese Mice: the Role of Endoplasmic Reticulum Stress.

Deletion of the RabGAP TBC1D1 Leads to Enhanced Insulin Secretion and Fatty Acid Oxidation in Islets From Male Mice

Enhanced Acyl-Coa:Cholesterol Acyltransferase Activity Increases Cholesterol Levels on the Lipid Droplet Surface and Impairs Adipocyte Function

Characterization of Signaling Pathways Associated with Pancreatic β-cell Adaptive Flexibility in Compensation of Obesity-linked Diabetes in db/db Mice